Dr. Reusch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1700 Wheeling St
Aurora, CO 80045Phone+1 913-578-4409
Summary
- Jane EB Reusch, MD is a Professor of Medicine, Bioengineering and Integrative Physiology, and Associate Director of the Center for Women’s Health Research, Anschutz Medical Campus and staff physician and merit investigator at the Rocky Mountain Regional VAMC. She is an elected member of American Society for Clinical Investigation, American Association of Physicians and the American Diabetes Association 2018 President for Medicine and Science. She is currently working with the ADA, AHA and ACC on global strategies to decrease the cardiovascular burden of diabetes. She is dedicated to recruiting and mentoring the translational research workforce, especially in women’s health and diabetes.
A physician-scientist, Dr. Reusch has made fundamental contributions to our understanding of cellular metabolism of diabetes and its complications. The focus of her basic science program is to identify the cellular and molecular mechanisms (i.e. mitochondrial dysfunction) that contribute to cardiac, vascular and skeletal muscle dysfunction in diabetes. Her shared clinical translational research program with Dr Judy Regensteiner examines and targets the biological variables in people with diabetes, particularly women, that lead to decreased functional exercise capacity and shortened lifespan.
Education & Training
- University of ColoradoFellowship, Endocrinology, Diabetes, and Metabolism, 1989 - 1992
- University of ColoradoResidency, Internal Medicine, 1986 - 1989
- University of Minnesota Medical SchoolClass of 1986
- University of Notre DameBS, Biology and Theology, Cum Laude, 1977 - 1981
- University of Notre DameB.S., Cum Laude, 1977 - 1981
Certifications & Licensure
- CO State Medical License 1990 - 2025
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Elected Member American Association of Physicians AAP, 2005
- Fellow Executive Leadership in Academic Medicine (ELAM), 2011
- Clinical Merit Review Award VA, 2007
- Join now to see all
Clinical Trials
- Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 Diabetes Start of enrollment: 2013 Oct 01
- Role of Microvascular Insulin Resistance and Cardiorespiratory Fitness Diabetes Start of enrollment: 2022 Jun 17
Publications & Presentations
PubMed
- 47 citationsAre low-income elderly patients at risk for poor diabetes care?Daniel T. McCall, Angela Sauaia, Richard F. Hamman, Jane E.B. Reusch, Phoebe Barton
Diabetes Care. 2004-05-01 - 12 citationsGlucagon-like peptide-1 receptor antagonism impairs basal exercise capacity and vascular adaptation to aerobic exercise training in rats.Rebecca L. Scalzo, Leslie A. Knaub, Sara E. Hull, Amy C. Keller, Kendall S. Hunter
Physiological Reports. 2018-07-01 - 52 citationsExenatide improves diastolic function and attenuates arterial stiffness but does not alter exercise capacity in individuals with type 2 diabetes.Rebecca L. Scalzo, Kerrie L. Moreau, Cemal Ozemek, Leah Herlache, Shawna McMillin
Journal of Diabetes and Its Complications. 2017-02-01
Journal Articles
- PhD Exenatide improves diastolic cardiac and endothelial function but not exercise capacity in individuals with type 2 diabetesScalzo RL, Herlache L, McMillin S, Gilligan S, Huebschmann AG, Bauer TA, Dorosz J, Reusch JEB* and Regensteiner JG, J Diabetes Complications, 1/7/2016
- The Endothelial Glycocalyx Promotes Homogeneous Blood Flow Distribution within the MicrovasculatureMcClatchey PM, Schafer M, Hunter KS, Reusch JEB, Am J Physiol Heart Circ Physiol, 1/1/2016
- Liraglutide and Cardiovascular Outcomes in Type 2 DiabetesMarso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, B..., Diabetes N Engl J Med, 1/1/2016
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Oxygen-carrying capacity is impaired by lipid/heparin infusion in young healthy adultsMcClatchey PM, Reusch JEB, Regensteiner JG, Schauer IE, 1/1/2016
- The Endothelial Glycocalyx Promotes Homogenous Blood Flow Distribution Within the MicrovasculatureMcClatchey PM, Schafer M, Hunter KS, Reusch JEB, AHA-ATVB meeting, Nashville, TN, 1/1/2016
- Novel insights into mitochondrial dysfunction in diabetes: muscle oxidative function and O2 delivery limitationsCree-Green M, McClatchey PM, Bauer T, Knaub L, McMillin S, Leavitt I, Schauer IE, Regensteiner JG, Reusch JEB, NIH Mitochondrial Symposium, Bethesda, MD, 1/1/2016
- Join now to see all
Lectures
- Women’s Networking, Exercise, and Debates: My Experience at ADA 2020Aurora, CO - 6/15/2014
- Emerging Aspects of Adaptations to ExerciseENDO 2019 - New Orleans, LA - 3/24/2019
- Master Clinician: Management of Diabetes: Selecting Therapy Based on CVD Outcomes and BeyondENDO 2019 - New Orleans, LA - 3/24/2019
- Join now to see all
Authored Content
- ADA 2022: A Personal ReflectionJune 2022
- Reflections on a Virtual ENDO 2021 MeetingMarch 2021
- Women’s Networking, Exercise, and Debates: My Experience at ADA 2020June 2020
Press Mentions
- Sex-Specific Guidelines Needed for Treating Obesity, Hypertension and Diabetes in WomenApril 11th, 2022
- University of Colorado Tops $1 Billion in Sponsored Research Funding for Fourth Consecutive YearOctober 8th, 2020
- Top Designation for CU Anschutz Medical Campus Expands Research ReachSeptember 28th, 2020
- Join now to see all
Professional Memberships
- President Elect Medicine and Science
- Member
- Member
- American Federation for Medical ResearchMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: